Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

China Diagnostics Medical Raises $292 Million led by Legend's $100 Million

publication date: Aug 1, 2018

China Diagnostics Medical of Beijing raised $292 million in a fundraising led by Legend Capital, a China private equity firm, which contributed $100 million of the total. Founded in 1999, CDM designs and develops diagnostic testing reagents, including biochemical, chemiluminescence and radioactive reagents. China Renaissance’s healthcare fund co-led the round. CDM claims it prices its HIV reagents at about one-third the price of comparable HIV reagents from multinational biopharmas. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital